|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2008-4-10
|
|
pubmed:abstractText |
Recently it was found that thyrotropin (TSH) receptors are present both in osteoclast and osteoblast and that TSH can modulate bone remodeling independent of thyroid hormones. The aim of this study was, firstly, to evaluate the effects of acute administration of TSH on bone remodeling markers both in men and in women and, secondly, to evaluate if these effects are mediated by variations in serum osteoprotegerin (OPG) and receptor activator of nuclear factor-KB ligand (RANKL).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1050-7256
|
|
pubmed:author |
pubmed-author:AvanzatiAnnalisaA,
pubmed-author:CampagnaStellaS,
pubmed-author:De PaolaVincenzoV,
pubmed-author:FranciBeatriceB,
pubmed-author:GennariLuigiL,
pubmed-author:MartiniGiuseppeG,
pubmed-author:MerlottiDanielaD,
pubmed-author:NutiRanuccioR,
pubmed-author:PaciniFurioF,
pubmed-author:PilliTaniaT,
pubmed-author:SalvadoriStefaniaS,
pubmed-author:ValleggiFabrizioF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
455-60
|
|
pubmed:meshHeading |
pubmed-meshheading:18399769-Adult,
pubmed-meshheading:18399769-Aged,
pubmed-meshheading:18399769-Bone and Bones,
pubmed-meshheading:18399769-Female,
pubmed-meshheading:18399769-Humans,
pubmed-meshheading:18399769-Male,
pubmed-meshheading:18399769-Middle Aged,
pubmed-meshheading:18399769-Osteoprotegerin,
pubmed-meshheading:18399769-RANK Ligand,
pubmed-meshheading:18399769-Recombinant Proteins,
pubmed-meshheading:18399769-Thyroid Neoplasms,
pubmed-meshheading:18399769-Thyroidectomy,
pubmed-meshheading:18399769-Thyrotropin,
pubmed-meshheading:18399769-Thyroxine,
pubmed-meshheading:18399769-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The effects of recombinant TSH on bone turnover markers and serum osteoprotegerin and RANKL levels.
|
|
pubmed:affiliation |
Department of Internal Medicine, Endocrinology & Metabolism and Biochemistry, Section of Internal Medicine, University of Siena, Siena, Italy. martinig@unisi.it
|
|
pubmed:publicationType |
Journal Article
|
